Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department. [electronic resource]
Producer: 20210127Description: 2570-2573 p. digitalISSN:- 1532-8171
- Adult
- Aged
- Anti-Bacterial Agents -- therapeutic use
- Aztreonam -- therapeutic use
- Cefepime -- therapeutic use
- Centers for Medicare and Medicaid Services, U.S
- Early Diagnosis
- Early Medical Intervention
- Emergency Service, Hospital
- Female
- Guideline Adherence
- Hospital Mortality
- Hospitalization
- Humans
- Male
- Medical Overuse -- statistics & numerical data
- Meropenem -- therapeutic use
- Middle Aged
- Patient Care Bundles
- Piperacillin, Tazobactam Drug Combination -- therapeutic use
- Reimbursement Mechanisms
- Retrospective Studies
- Sepsis -- diagnosis
- Shock, Septic -- diagnosis
- Soft Tissue Infections -- drug therapy
- Time-to-Treatment -- statistics & numerical data
- United States
- Urinary Tract Infections -- drug therapy
- Vancomycin -- therapeutic use
- beta-Lactams -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.